Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2
about
Illicit dopamine transients: reconciling actions of abused drugsAmphetamine elicits opposing actions on readily releasable and reserve pools for dopamineMethod development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesiclesCocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activationAnnual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbensMethylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kBAmphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder.Adverse effects of 2,4-dichlorophenoxyacetic acid on rat cerebellar granule cell cultures were attenuated by amphetamine.Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD.Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septum.
P2860
Q26997102-325BB357-FF6D-4CD5-B773-655B1276D44EQ28487647-F6847B21-BF8C-4B4D-8B1A-9CB22BE1607DQ28575786-F10F773F-8C19-4ADA-B332-5D3D2F2290DBQ28576129-A1D950A4-C570-438C-A0D4-2FA71D14E5D7Q30469044-48E33C8F-3779-4004-9EF0-8E559154A8D0Q36361756-78BB4AA0-5A3E-4089-8043-1B8EF0B2359AQ36952043-2DCDDFAF-CB64-48FD-8EE2-DDA174B1F9ECQ37081344-F9008369-51B9-4A4A-BAFD-7AEF137A3221Q37446868-1FD67A3C-A6C9-4CBE-92F6-87369A1351DEQ40023238-496154C4-4701-474B-90BC-1FA8EE2A5120Q46890815-7FD9E355-C83A-4701-A323-37B241C16792Q48240210-3F580538-39A4-4934-BD99-2336CBE6969AQ50684186-4F4ECD6E-694A-4966-8A4D-4FC872007548Q52304525-98CE0851-FC45-4109-B2A8-916EF25A9736
P2860
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic doses of amphetami ...... icular monoamine transporter-2
@en
type
label
Therapeutic doses of amphetami ...... icular monoamine transporter-2
@en
prefLabel
Therapeutic doses of amphetami ...... icular monoamine transporter-2
@en
P2093
P2860
P1476
Therapeutic doses of amphetami ...... icular monoamine transporter-2
@en
P2093
Annette E Fleckenstein
Evan L Riddle
Glen R Hanson
P2860
P356
10.1016/J.EJPHAR.2007.05.044
P407
P577
2007-06-05T00:00:00Z